See All Slides - tctmd.com

Slides

Presentation TCT 2025

Lessons I Learned From My Most Memorable Unusual MI Intervention

Presenter: Ahmed Magdy

October 27, 2025

Presentation TCT 2025

My Approach to Commissural Jets

Presenter: Neil P. Fam

October 27, 2025

Presentation TCT 2025

TCT 525: Cutting Balloon versus Standard Balloon for Lesion Preparation of Drug-Coated Balloon Treatment in De-novo Coronary Artery Lesions: Primary Endpoint of the Randomized NATURE Trial

Presenter: Ken Kozuma

October 27, 2025

Presentation TCT 2025

Cephea™ Mitral Valve System for Symptomatic Mitral Valve Disease: 1-Year Outcomes of the Early Feasibility Study

Presenter: Torsten P. Vahl

October 27, 2025

Presentation TCT 2025

TCT 1046: Impact of Concomitant Deep-Vein Thrombosis on Pulmonary Embolism Care and Outcomes

Presenter: Quinn Mallery

October 27, 2025

Presentation TCT 2025

TCT 470: Comparative Outcomes of Serum LDL Levels <55 mg/dL Versus 55–100 mg/dL for Primary Prevention of Undiagnosed Coronary Artery Disease: A Retrospective Cohort Study

Presenter: Mehmet Cilingiroglu

October 27, 2025

Presentation TCT 2025

Case Intro: ACS 3 Vessel Disease Low EF

Presenter: Judit Karacsonyi

October 27, 2025

Presentation TCT 2025

Linkage of Clinical Trial Evidence with Administrative Claims: Pros and Cons

Presenter: Eric A. Secemsky

October 27, 2025

Presentation TCT 2025

SELUTION DeNovo Discussion

Presenter: Christian M. Spaulding

October 27, 2025

Presentation TCT 2025

Optimizing Patients and Lesions for Coronary DCB: Imaging and Physiology

Presenter: Deborah JinHyun Lee

October 27, 2025

Advertisement

Slides

Lessons I Learned From My Most Memorable Unusual MI Intervention

My Approach to Commissural Jets

TCT 525: Cutting Balloon versus Standard Balloon for Lesion Preparation of Drug-Coated Balloon Treatment in De-novo Coronary Artery Lesions: Primary Endpoint of the Randomized NATURE Trial

Cephea™ Mitral Valve System for Symptomatic Mitral Valve Disease: 1-Year Outcomes of the Early Feasibility Study

TCT 1046: Impact of Concomitant Deep-Vein Thrombosis on Pulmonary Embolism Care and Outcomes

TCT 470: Comparative Outcomes of Serum LDL Levels <55 mg/dL Versus 55–100 mg/dL for Primary Prevention of Undiagnosed Coronary Artery Disease: A Retrospective Cohort Study

Case Intro: ACS 3 Vessel Disease Low EF

Linkage of Clinical Trial Evidence with Administrative Claims: Pros and Cons

SELUTION DeNovo Discussion

Optimizing Patients and Lesions for Coronary DCB: Imaging and Physiology

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content